Previous 10 | Next 10 |
Summary ARK Genomic Revolution ETF invests in small-cap and mid-cap companies engaged in genomic revolution, i.e., in the research of genomic sequencing, analysis, synthesis, or instrumentation. Alpha-generating stocks ARKG selects from time to time and backs for a longer time period ha...
Summary CRISPR Therapeutics AG is a gene editing company based on CRISPR/Cas9 technology. CRISPR method seems to be the preferred in Gene Editing. CRSP has a rich pipeline. CRISPR seems to be the preferable Gene Editing Method and CRISPR Therapeutics AG ( CRSP ) could ...
BOSTON, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics , a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Sekar Kathiresan, M.D., co-founder and chief executive officer,...
Cathie Wood is hoping to catch 2020 in a bottle again. The co-founder, CEO, and lead stock picker of Ark Invest delivered jaw-dropping returns two years ago across her family of funds, but her stock-picking skills have proven mortal in 2021 and 2022. Can she get back on track in 2023? Wood ad...
Summary Beam Therapeutics announced the recruitment of its first BEACON trial patient in the middle of November 2022. BEAM's announcement was followed by Editas Medicine's declaration of positive safety and efficacy data from its first two patients enrolled and treated under the Ruby tr...
Summary The science is as exciting as it gets - precision gene editing! Verve Therapeutics is working to provide new alternatives for the treatment of cardiovascular disease (CVD). While the science is exciting and the market opportunity very significant, the valuation may not...
The following slide deck was published by Verve Therapeutics, Inc. in conjunction with this event. For further details see: Verve Therapeutics (VERV) Investor Presentation - Slideshow
Verve Therapeutics (NASDAQ: VERV) , a clinical-stage gene-editing biopharmaceutical that focuses on cardiovascular therapies, saw its share price plummet 26.33% as of Monday afternoon. The stock closed on Friday at $31.29 and opened on Monday at $24.45. It fell to as low as $21.62 b...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock IAA (NYSE: IAA ) stock is climbing higher on Monday thanks to a massive acquisition deal with Ritchie Bros Auctioneers (NYSE: RBA ). Ritchie Bros have agreed to acquire IAA in a dea...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: JHVEPhoto / Shutterstock.com Verve Therapeutics (NASDAQ: VERV ) stock is taking a beating on Monday following bad news from the FDA. The unfortunate news for VERV shareholders is the FDA putting the ...
News, Short Squeeze, Breakout and More Instantly...
Verve Therapeutics Inc. Company Name:
VERV Stock Symbol:
NASDAQ Market:
Verve Therapeutics Inc. Website:
2024-07-08 07:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics , a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its boar...
2024-06-15 11:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...